Suono Bio

Suono Bio is developing therapeutic products for inflammation-mediated diseases, leveraging its ultrafast and formulation-independent delivery technology, which aims to enable therapeutics, including proteins and nucleic acids, to enter the gastrointestinal (GI) tract at an ultrafast rate. Preclinical studies have demonstrated that Suono Bio's platform can achieve rapid, localized delivery of small molecules, biologics, nucleic acids, and gene therapies without the need for encapsulation.